Filter
8
Filtered Results: 8
Text search:
Venuti,
F.
et
al.
Featured
New Publications
1
Language
Document type
Studies & Reports
6
Guidelines
1
No document type
1
Countries / Regions
Italy
2
West and Central Africa
1
East and Southern Africa
1
Authors & Publishers
Publication Years
Category
COVID-19
2
Surgery & Anaesthesia
1
Toolboxes
Country specific documents
2
Immunization Guidelines
1
Booster Doses
1
Agriculture
1
Agriculture incl. animal husbandry
1
Zoonoses
1
Studies & Reports
1
Scabies
1
War Surgery & Wound Care
1
Global Health Action
1
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv...
Rapporto ISS COVID-19, n. 3/2020
Gruppo di Lavoro ISS Ambiente e Gestione dei Rifiuti
aggiornato al 14 marzo 2020
Rapporto ISS COVID-19, n. 4/2020
Gruppo di Lavoro ISS Prevenzione e Controllo delle Infezioni
aggiornato al 16 marzo 2020
Several Public Health Services and general practitioners in the Netherlands observed an increase in scabies in the Netherlands. Since individual cases of scabies are not notifiable in the Netherlands, the epidemiological situation is mostly unknown. To investigate the scabies incidence in the Nether...
These country profiles present progress on implementation of policy recommendations of the Global Action Plan on Physical Activity (GAPPA) 2018-2030 in each country. They also present an estimate of the cost to health systems of not taking action to improve physical activity levels and reinforce th...
27 April 2022 Chronic land degradation: UN offers stark warnings and practical remedies in Global Land Outlook 2. GLO2 offers hundreds of examples from around the world that demonstrate the potential of land restoration.
The way land resources – soil, water and biodiversity – are currently mi...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
